Specific coenzyme preference switching for an aldo-keto reductase that synthesizes the chiral intermediate of duloxetine
Enzyme and Microbial Technology · 2023
DOI: 10.1016/j.enzmictec.2023.110326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Enzyme and Microbial Technology, 2023. Verfasst von Lingzhi Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical Engineering, Huaqiao University, Xiamen 361021, Fujian Province, PR China. Hauptthemen laut MEDLINE: Duloxetine Hydrochloride, Aldo-Keto Reductases, Coenzymes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
The synthesis of chiral intermediates for the traditional antidepressant duloxetine has gained significant attention as the number of depressed patients continues to grow. S-N, N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamide (S-DHTP) is a critical intermediate in the synthesis of duloxetine, and the chemical synthesis process is complex and environmentally unfriendly. Reduced nicotinamide adenine dinucleotide phosphate (NADPH) is a major cost driver in the biocatalytic production of S-DHTP from N, N-Dimethyl-3-keto-3-(2-thienyl)-1-propanamide (DKTP). Here, we successfully modified the coenzyme preference of an aldo-keto reductase (AKR7-2-1) to use the cheaper reduced nicotinamide adenine dinucleotide (NADH) through a coenzyme preference modification approach. We utilized protein engineering to create a superior mutant, Y53F, which increased the coenzyme specificity of AKR7-2-1 by 875-fold and improved its thermal stability, enhancing its potential for industrial applications. Molecular dynamics simulations were performed to demonstrate the effect of mutations at key sites on the protein, revealing the altered coenzyme preference and increased thermal stability from structural and energetic changes. This study validates the viability of the coenzyme preference modification strategy for aldo-keto reductase, offering valuable insights for fellow researchers and guiding future investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemical Engineering, Huaqiao University, Xiamen 361021, Fujian Province, PR China.
- State Key Laboratory of Microbial Technology, Shandong University, No. 72 Binhai Road, Qingdao 266237, PR China.
- College of Chemical Engineering, Huaqiao University, Xiamen 361021, Fujian Province, PR China. Electronic address: szhou@hqu.edu.cn.
- College of Chemical Engineering, Huaqiao University, Xiamen 361021, Fujian Province, PR China. Electronic address: wjiang@hqu.edu.cn.
Zitieren
APA
Zhang, L., Zhou, R., Fu, X., Zhang, G., Zhang, L., Zhou, S. F., & Jiang, W. (2023). Specific coenzyme preference switching for an aldo-keto reductase that synthesizes the chiral intermediate of duloxetine. Enzyme and Microbial Technology. https://doi.org/10.1016/j.enzmictec.2023.110326
Vancouver
Zhang L, Zhou R, Fu X, Zhang G, Zhang L, Zhou SF, et al. Specific coenzyme preference switching for an aldo-keto reductase that synthesizes the chiral intermediate of duloxetine. Enzyme and Microbial Technology. 2023. doi:10.1016/j.enzmictec.2023.110326
BibTeX
@article{Zhang2023,
author = {Zhang, Lingzhi and Zhou, Rui and Fu, Xiaoli and Zhang, Guangya and Zhang, Lijuan and Zhou, Shu-Feng and Jiang, Wei},
title = {Specific coenzyme preference switching for an aldo-keto reductase that synthesizes the chiral intermediate of duloxetine},
journal = {Enzyme and Microbial Technology},
year = {2023},
doi = {10.1016/j.enzmictec.2023.110326}
}
EUVIMED